Opendata, web and dolomites

CTI

A novel, efficient and minimally invasive medical procedure to treat anastomotic leakage during colorectal cancer surgery.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CTI project word cloud

Explore the words cloud of the CTI project. It provides you a very rough idea of what is the project "CTI" about.

aragon    loop    ebola    tecnoline    authorized    prototype    despite    cti    die    transcaecal    18    hires    2018    turnover    environmental    nowadays    surgical    disease    modena    reoccurrence    experimental    period    worried    ileostomy    transport    diminish    anastomotic    ago    recovery    feces    hospitals    reduce    translated    99    decided    boost    invest    least    impacts    630    mortality    stay    decrease    invention    team    2025    220    permits    surgery    round    rates    alternative    morbidity    people    patient    1992    positive    started    defunction    91m    technique    launched    rectal    italy    plastic    clinical    time    area    connected    right    tests    moment    roll    innovation    50    disposable    population    solution    patients    leakage    risk    founded    pouches    cancer    animal    hospital    medical    efficient    ethical    trl7    passed    market    readiness    spain    replace    start    committee    catheter    2014    anastomoses    complications    it    97    successfully    preparing    energy    company    tumor    improvements    colorectal    safer    diagnosed    treatment   

Project "CTI" data sheet

The following table provides information about the project.

Coordinator
TECNOLINE SPA 

Organization address
address: VIA GELATTI 11/A
city: CONCORDIA SULLA SECCHIA
postcode: 41033
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website https://www.tecnolinesrl.org/shop/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECNOLINE SPA IT (CONCORDIA SULLA SECCHIA) coordinator 50˙000.00

Map

 Project objective

It is estimated that in 2018, 97,220 people will be diagnosed with colorectal cancer and that about 50,630 people will die from this disease; making treatment this cancer to be of growing importance nowadays. Despite improvements in the area of surgical treatment of the tumor, there are still many risk factors connected with mortality, recovery and reoccurrence rates, as well as complications (like anastomotic leakage).

After having successfully launched an innovation that permits the transport of Ebola patients in 2014, Tecnoline (a medical company founded in 1992 in Modena, Italy) decided to invest into innovation development for the surgical treatment of colorectal cancer. Three years ago the team started developing a prototype of the Catheter for Transcaecal Ileostomy (CTI), an alternative technique to loop ileostomy to defunction low rectal anastomoses. Our company conducted a positive round of animal and clinical tests.

The new invention is capable to decrease morbidity and mortality rates due to anastomotic leakage and surgery complications; diminish the hospital stay and ‘worried well’ by 50%; reduce the operating time by at least 50% and up to 99% leakage of feces. It also have a positive environmental impact since it replace the disposable plastic pouches and reduce energy use and other impacts connected with the patients stay in the hospitals. Finally, this invention has the potential to boost the company growth, translated into 8.91M€ of turnover (2025) and 40 new hires for the development period.

Tecnoline was authorized by the Ethical Committee of Aragon (Spain) to implement CTI in a patient population in Aragon (18 patients). The solution has just passed through the experimental process and therefore reaches TRL7. Thus, it is the right moment to start preparing the CTI market readiness and roll-out to provide the medical sector with a unique solution that makes treatment of colorectal cancer patients safer, more efficient and effective.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CTI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CTI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TuneFork (2018)

Mobile technology that brings personalized audio into your life

Read More  

GREEN WHS (2019)

NATURE FRIENDLY WATER HYDRAULIC STEERING SYSTEM

Read More  

PrasinoMed (2018)

First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatus

Read More